Principal Securities, Inc. Immunocore Holdings PLC Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Principal Securities, Inc. holds 81 shares of IMCR stock, worth $2,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81
Previous 69
17.39%
Holding current value
$2,705
Previous $4.49 Million
38.8%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$213 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$163 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$99.9 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$94.6 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$65.2 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.47B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...